Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies

Serge Vulliémoz, G Vanini, André Truffert, Carlo Chizzolini, Margitta Seeck

Journal of Neurology Neurosurgery & Psychiatry · 2007 · 72 citations · 20 references

DOIFull text

Open access

Concepts

Abstract

Anti-glutamic acid decarboxylase (GAD) antibodies are described in stiff-person syndrome and also in other neurological syndromes, including cerebellar ataxia and epilepsy. This paper reports the case of a patient who had chronic focal epilepsy, upbeat nystagmus and cerebellar ataxia, associated with a polyautoimmune response including anti-GAD antibodies. Both gait and nystagmus improved markedly after immunosuppressive treatment with corticosteroids and azathioprine. After the introduction of benzodiazepines, previously refractory seizures were completely controlled. Anti-GAD antibodies should be actively sought out in pharmacoresistant epilepsy, particularly if other neurological abnormalities are present. Combined treatment with immunosuppressants and gammahydroxybutyric acidergic agents may be highly effective.

References

20